Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 48

  • Quoted phrase not found.
1.

Combined Heart and Liver Transplantation: The Cedars-Sinai Experience.

Reich HJ, Awad M, Ruzza A, De Robertis MA, Ramzy D, Nissen N, Colquhoun S, Esmailian F, Trento A, Kobashigawa J, Czer LS.

Transplant Proc. 2015 Nov;47(9):2722-6. doi: 10.1016/j.transproceed.2015.07.038.

PMID:
26680081
2.

Echocardiographic evaluation of pre-diagnostic development in young relatives genetically predisposed to hypertrophic cardiomyopathy.

Jensen MK, Havndrup O, Christiansen M, Andersen PS, Axelsson A, Køber L, Bundgaard H.

Int J Cardiovasc Imaging. 2015 Dec;31(8):1511-8. doi: 10.1007/s10554-015-0723-x. Epub 2015 Aug 1.

PMID:
26231341
3.

Merits and pitfalls of genetic testing in a hypertrophic cardiomyopathy clinic.

Arad M, Monserrat L, Haron-Khun S, Seidman JG, Seidman CE, Arbustini E, Glikson M, Freimark D.

Isr Med Assoc J. 2014 Nov;16(11):707-13.

4.

Novel genotype-phenotype associations demonstrated by high-throughput sequencing in patients with hypertrophic cardiomyopathy.

Lopes LR, Syrris P, Guttmann OP, O'Mahony C, Tang HC, Dalageorgou C, Jenkins S, Hubank M, Monserrat L, McKenna WJ, Plagnol V, Elliott PM.

Heart. 2015 Feb;101(4):294-301. doi: 10.1136/heartjnl-2014-306387. Epub 2014 Oct 28.

5.

Atlas of the clinical genetics of human dilated cardiomyopathy.

Haas J, Frese KS, Peil B, Kloos W, Keller A, Nietsch R, Feng Z, Müller S, Kayvanpour E, Vogel B, Sedaghat-Hamedani F, Lim WK, Zhao X, Fradkin D, Köhler D, Fischer S, Franke J, Marquart S, Barb I, Li DT, Amr A, Ehlermann P, Mereles D, Weis T, Hassel S, Kremer A, King V, Wirsz E, Isnard R, Komajda M, Serio A, Grasso M, Syrris P, Wicks E, Plagnol V, Lopes L, Gadgaard T, Eiskjær H, Jørgensen M, Garcia-Giustiniani D, Ortiz-Genga M, Crespo-Leiro MG, Deprez RH, Christiaans I, van Rijsingen IA, Wilde AA, Waldenstrom A, Bolognesi M, Bellazzi R, Mörner S, Bermejo JL, Monserrat L, Villard E, Mogensen J, Pinto YM, Charron P, Elliott P, Arbustini E, Katus HA, Meder B.

Eur Heart J. 2015 May 7;36(18):1123-35a. doi: 10.1093/eurheartj/ehu301. Epub 2014 Aug 27.

6.

Significance of sarcomere gene mutations analysis in the end-stage phase of hypertrophic cardiomyopathy.

Biagini E, Olivotto I, Iascone M, Parodi MI, Girolami F, Frisso G, Autore C, Limongelli G, Cecconi M, Maron BJ, Maron MS, Rosmini S, Formisano F, Musumeci B, Cecchi F, Iacovoni A, Haas TS, Bacchi Reggiani ML, Ferrazzi P, Salvatore F, Spirito P, Rapezzi C.

Am J Cardiol. 2014 Sep 1;114(5):769-76. doi: 10.1016/j.amjcard.2014.05.065. Epub 2014 Jun 19.

PMID:
25037680
7.

Early changes in apical rotation in genotype positive children with hypertrophic cardiomyopathy mutations without hypertrophic changes on two-dimensional imaging.

Forsey J, Benson L, Rozenblyum E, Friedberg MK, Mertens L.

J Am Soc Echocardiogr. 2014 Feb;27(2):215-21. doi: 10.1016/j.echo.2013.10.012. Epub 2013 Dec 8.

PMID:
24325958
8.

Confirmation of cause and manner of death via a comprehensive cardiac autopsy including whole exome next-generation sequencing.

Loporcaro CG, Tester DJ, Maleszewski JJ, Kruisselbrink T, Ackerman MJ.

Arch Pathol Lab Med. 2014 Aug;138(8):1083-9. doi: 10.5858/arpa.2013-0479-SA. Epub 2013 Dec 3.

PMID:
24298987
9.

Cardiac findings in Noonan syndrome on long-term follow-up.

Colquitt JL, Noonan JA.

Congenit Heart Dis. 2014 Mar-Apr;9(2):144-50. doi: 10.1111/chd.12102. Epub 2013 Jun 10.

PMID:
23750712
10.

Diagnostic approach and differential diagnosis in patients with hypertrophied left ventricles.

Yilmaz A, Sechtem U.

Heart. 2014 Apr;100(8):662-71. doi: 10.1136/heartjnl-2011-301528. Epub 2013 Apr 30. Review. No abstract available.

PMID:
23633547
11.

Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives.

Maron BJ, Maron MS, Semsarian C.

J Am Coll Cardiol. 2012 Aug 21;60(8):705-15. doi: 10.1016/j.jacc.2012.02.068. Epub 2012 Jul 11. Review.

12.

Myocardial structural alteration and systolic dysfunction in preclinical hypertrophic cardiomyopathy mutation carriers.

Yiu KH, Atsma DE, Delgado V, Ng AC, Witkowski TG, Ewe SH, Auger D, Holman ER, van Mil AM, Breuning MH, Tse HF, Bax JJ, Schalij MJ, Marsan NA.

PLoS One. 2012;7(5):e36115. doi: 10.1371/journal.pone.0036115. Epub 2012 May 4.

13.

Inclusion body myositis coexisting with hypertrophic cardiomyopathy: an autopsy study.

Inamori Y, Higuchi I, Inoue T, Sakiyama Y, Hashiguchi A, Higashi K, Shiraishi T, Okubo R, Arimura K, Mitsuyama Y, Takashima H.

Neuromuscul Disord. 2012 Aug;22(8):747-54. doi: 10.1016/j.nmd.2012.03.011. Epub 2012 May 4.

PMID:
22560514
14.

The clinical management of relatives of young sudden unexplained death victims; implantable defibrillators are rarely indicated.

Caldwell J, Moreton N, Khan N, Kerzin-Storrar L, Metcalfe K, Newman W, Garratt CJ.

Heart. 2012 Apr;98(8):631-6. doi: 10.1136/heartjnl-2011-300924.

PMID:
22505462
15.

Long-term outcomes of patients bridged to recovery versus patients bridged to transplantation.

Birks EJ, George RS, Firouzi A, Wright G, Bahrami T, Yacoub MH, Khaghani A.

J Thorac Cardiovasc Surg. 2012 Jul;144(1):190-6. doi: 10.1016/j.jtcvs.2012.03.021. Epub 2012 Apr 11.

16.

Microvascular function is selectively impaired in patients with hypertrophic cardiomyopathy and sarcomere myofilament gene mutations.

Olivotto I, Girolami F, Sciagrà R, Ackerman MJ, Sotgia B, Bos JM, Nistri S, Sgalambro A, Grifoni C, Torricelli F, Camici PG, Cecchi F.

J Am Coll Cardiol. 2011 Aug 16;58(8):839-48. doi: 10.1016/j.jacc.2011.05.018.

17.

Multi-scale computational models of familial hypertrophic cardiomyopathy: genotype to phenotype.

Campbell SG, McCulloch AD.

J R Soc Interface. 2011 Nov 7;8(64):1550-61. doi: 10.1098/rsif.2011.0184. Epub 2011 Aug 10. Review.

18.

Profound left ventricular remodeling associated with LAMP2 cardiomyopathy.

Maron BJ, Roberts WC, Ho CY, Kitner C, Haas TS, Wright GB, Moazami N, Feldman DS.

Am J Cardiol. 2010 Oct 15;106(8):1194-6. doi: 10.1016/j.amjcard.2010.06.035.

PMID:
20920663
19.

Heart Rhythm UK position statement on clinical indications for implantable cardioverter defibrillators in adult patients with familial sudden cardiac death syndromes.

Garratt CJ, Elliott P, Behr E, Camm AJ, Cowan C, Cruickshank S, Grace A, Griffith MJ, Jolly A, Lambiase P, McKeown P, O'Callagan P, Stuart G, Watkins H; Heart Rhythm UK Familial Sudden Cardiac Death Syndromes Statement Development Group.

Europace. 2010 Aug;12(8):1156-75. doi: 10.1093/europace/euq261.

20.

Maps of beauty and disease: thoughts on genetics, confidentiality, and biological family.

Ladd M.

J Med Ethics. 2010 Aug;36(8):479-82. doi: 10.1136/jme.2009.033514.

PMID:
20663765
Items per page

Supplemental Content

Loading ...
Write to the Help Desk